Overview and Scope
Dry eye syndrome, commonly known as dry eye illness, is a common disorder in which the eyes either do not produce enough tears or produce poor-quality tears. Dry eye occurs when your eyes do not produce enough tears to keep your eyes moist. This can cause discomfort, irritation, and inflammation of the eyes.
Sizing and Forecast
The dry eye syndrome market size has grown strongly in recent years. It will grow from $3.68 billion in 2023 to $3.96 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to healthcare accessibility, evolving treatment options, medications and health conditions, hormonal changes, ocular surgery impact.
The dry eye syndrome market size is expected to see strong growth in the next few years. It will grow to $5.23 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to aging population demographics, increasing screen usage, shift in lifestyle habits, healthcare awareness and accessibility, ocular surgery trends, development of novel therapies. Major trends in the forecast period include holistic approach to eye health, integration of ai in eye care, telemedicine and remote consultations, personalized medicine approach, rise in awareness and education.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/dry-eye-syndrome-global-market-report
The dry eye syndrome market covered in this report is segmented –
1) By Product: Liquid Drops, Gel, Liquid Wipes, Eye Ointment, Other Products
2) By Treatment: Corticosteroids, Artificial Tears, Oral Omega Supplements, Lubricating Agent, Other Treatments
3) By Disease Type: Evaporative, Aqueous
4) By Distribution Channel: Offline, Online
5) By Application: Hospitals And Clinics, Medical Laboratories, Other Applications
North America was the largest region in the dry eye syndrome market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global dry eye syndrome market report during the forecast period. The regions covered in the dry eye syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=10704&type=smp
Major Driver Impacting Market Growth
The growing prevalence of dry eye syndrome is expected to propel the growth of the dry eye syndrome market going forward. Dry eye syndrome is when eyes do not produce enough tears. Dry eye syndrome products and medications help treat dry eye syndrome by providing lubrication and moisture to the eyes, increasing tear production, improving tear quality, reducing inflammation, and protecting the ocular surface. For instance, in March 2022, according to a survey conducted by Eyes On Eyecare with 540 eyecare experts, a US-based eyecare professionals company, according to the report, 35 million Americans will suffer from dry eye disease (DED) in 2022, with the frequency increasing year after year. Furthermore, according to UpToDate Inc., a US-based health information provider, in 2022 meta-analysis of three US studies showed an 8.1% pooled prevalence of dry eye. Therefore, the rising prevalence of dry eye syndrome is driving the dry eye syndrome market.
Key Industry Players
Major companies operating in the dry eye syndrome market report are Allergan plc, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Santendo Pharmaceutical Co. Ltd., Sentiss Pharma Pvt. Ltd., Johnson & Johnson, Alcon Vision LLC, Akorn Operating Company LLC, Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., AbbVie Inc., GlaxoSmithKline plc, I-MED Pharma Inc., Hoffmann-La Roche AG, Acadia Pharmaceuticals Inc., AFT Pharmaceuticals, Horus Pharma, Mitotech, Novaliq GmbH, OASIS Medical, Prestige Consumer Healthcare, VISUfarma, Alimera Science, Auven Therapeutics, Kala Pharmaceuticals Inc., Nicox S.A., Emisphere Technologies Inc., EyeGate Pharmaceuticals Inc., ReVision Therapeutics Inc., Avedro Inc., Itear Medical, Transcend Medical Inc.
The dry eye syndrome market report table of contents includes:
1. Executive Summary
2. Dry Eye Syndrome Characteristics
3. Dry Eye Syndrome Trends And Strategies
4. Dry Eye Syndrome – Macro Economic Scenario
5. Global Dry Eye Syndrome Size and Growth
…..
32. Global Dry Eye Syndrome Competitive Benchmarking
33. Global Dry Eye Syndrome Competitive Dashboard
34. Key Mergers And Acquisitions In The Dry Eye Syndrome
35. Dry Eye Syndrome Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Overview and Scope Rehabilitation equipment refers to a wide range of devices and tools designed…
Overview and Scope Mushroom coffee is a beverage made by combining coffee with various types…
Overview and Scope Multi-cloud security refers to the strategies, practices, and technologies employed to protect…
Overview and Scope Language translation devices are electronic devices that translate spoken or written language…
Overview and Scope Reduced lactose whey is a type of whey protein that has undergone…
Overview and Scope Landfill gas capture and utilization refers to the process of collecting methane…